• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

If you're thinking of getting an injection for back pain, you might want to think again. A panel of experts has examined the ...

A new study suggests that daily taxifolin intake may support weight loss in older adults, possibly through brown fat ...

Entrada Therapeutics' innovative Endosomal Escape Vehicle platform, poised to revolutionize drug delivery. Click here to read ...

The results, published in The Lancet Diabetes and Endocrinology, showed that people in the sotagliflozin group had a 23 per cent reduction in the rate of heart attacks, strokes, and deaths from such ...

"They include the placebo effect in the percent efficacy of ... Then there's confirmation bias, where your brain is constantly searching for things that confirm a belief you already have.

Elizabeth Holmes is in prison for defrauding investors. Women entrepreneurs still say they can’t shake her bad blood.

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...

‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

Give until your pockets hurt.